2019
DOI: 10.1002/chem.201900289
|View full text |Cite
|
Sign up to set email alerts
|

Catalytic Asymmetric Hydrogenation of Dehydroamino Acid Esters with Biscarbamate Protection and Its Application to the Synthesis of xCT Inhibitors

Abstract: Catalytic asymmetric hydrogenation of dehydroamino acid esters with biscarbamate protection was examined for the first time to prepare optically active amino acids. The new method was successfully applied to the synthesis of new cystine–glutamate exchanger inhibitors.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 51 publications
(8 reference statements)
0
4
0
Order By: Relevance
“…We have reported the stereoselective synthesis of optically active N ‐benzoyl diaminosuberic acids (DAS) for the development of cystine‐glutamate exchanger (xCT) inhibitors (Scheme 4). [13] To this end, DuPHOS‐Rh‐catalyzed asymmetric reduction [14] was successfully applied to the stereoselective synthesis of four stereoisomers of 15 with different protecting groups on the amino groups. We expected that the same strategy would be applicable to the synthesis of 10 from 9 (Scheme 5).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…We have reported the stereoselective synthesis of optically active N ‐benzoyl diaminosuberic acids (DAS) for the development of cystine‐glutamate exchanger (xCT) inhibitors (Scheme 4). [13] To this end, DuPHOS‐Rh‐catalyzed asymmetric reduction [14] was successfully applied to the stereoselective synthesis of four stereoisomers of 15 with different protecting groups on the amino groups. We expected that the same strategy would be applicable to the synthesis of 10 from 9 (Scheme 5).…”
Section: Resultsmentioning
confidence: 99%
“…[16] 4-((R,Z)-4-acetamido-1-((tert-butyldimethylsilyl)oxy)-5-methoxy-5-oxopent-3-en-1-yl)-2,2-dimethyloxazolidine-3-carboxylate (9). To a solution of 13 [11] 13 1746, 1690, 1649, 1541, 1388, 1254, 1220, 1161, 1073, 1021, 964, 938, 833, 777, 721, 686, 588, 555, 519. 1 -(5R,7)-dihydroxy-heptanoic acid (1).…”
Section: Tert-butyl (R)-4-((r)-1-((tert-butyldimethylsilyl)oxy)but-3-mentioning
confidence: 99%
“…Among others, α-(dialkoxyphosphoryl)glycinates became the crucial synthetic tool commonly used for the synthesis of many natural products (including β-lactam antibiotics) or α,β-dehydro-α-amino acids by the Wadsworth-Emmons reaction [ 90 , 91 , 92 , 93 , 94 , 95 , 96 ]. As is known, hydrogenation of the latter compounds using chiral catalysts is considered to be one of the most general methods for the enantioselective synthesis of α-amino acids, including non-proteinogenic α-amino acids of diverse biological activities [ 97 , 98 , 99 , 100 ].…”
Section: 1-aminoalkyltriarylphosphonium Derivativesmentioning
confidence: 99%
“…Stereochemistry is an important factor in drug design because changes affect biological chemistry. , In rapadocins, differences in stereochemistry induced 200-fold changes in IC 50 (Figure S2). Furthermore, among diaminosuberic amino acid-derived compounds with two stereocenters yielding four stereoisomers, only a single stereoisomer among the four exhibited high inhibitory activity in the micromolar range against the amino acid transporter . Therefore, the diversification of stereochemistry is one of the important strategies for nature to generate natural products with a wide range of biological functions.…”
Section: Introductionmentioning
confidence: 99%